Unity Biotechnology Inc. (UBX) Dropped -8.27% or -1.05 To Price $11.64 On Thursday

Unity Biotechnology Inc. (UBX) dropped -8.27% or -1.05 to $11.64. It is near to 69110 shares traded, which is 28.3% compare to the average total volume 244217. The market cap of UBX is $492.54 million. The year to date change is -32.06%. The 52 week price range is from $11.64 to $24.56. Price of UBX have changed -11.88% during last week. It have changed -31.66% over last month, -19.07% over last 3 months, -23.78% over last 6 months and -23.78% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for UBX is 16.72. It is 43.64% above current price. The 52-week High is 24.56. It is 111.00% from the current price. The 52-week Low is 11.64. The stock hits 52-week low today.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of UBX is 9.49 on 2018-09-14. Short % to float is 5.95%. There are some statistics of UBX. It is has market cap $492.54 million. The share outstanding is 42.31 million. The average volume is 244217. The percent of top 15 Institution holding is 28.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of UBX is -30.98%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of UBX is -28.99%.


Share this post